KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Halozyme Therapeutics (HALO) over the last 14 years, with Q3 2025 value amounting to $1.43.

  • Halozyme Therapeutics' EPS (Weighted Average and Diluted) rose 3619.05% to $1.43 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.75, marking a year-over-year increase of 5728.48%. This contributed to the annual value of $3.43 for FY2024, which is 6339.47% up from last year.
  • Latest data reveals that Halozyme Therapeutics reported EPS (Weighted Average and Diluted) of $1.43 as of Q3 2025, which was up 3619.05% from $1.33 recorded in Q2 2025.
  • In the past 5 years, Halozyme Therapeutics' EPS (Weighted Average and Diluted) registered a high of $1.48 during Q3 2021, and its lowest value of $0.16 during Q2 2022.
  • Its 5-year average for EPS (Weighted Average and Diluted) is $0.71, with a median of $0.61 in 2023.
  • In the last 5 years, Halozyme Therapeutics' EPS (Weighted Average and Diluted) skyrocketed by 57500.0% in 2021 and then plummeted by 7419.35% in 2022.
  • Over the past 5 years, Halozyme Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at $0.46 in 2021, then decreased by 8.7% to $0.42 in 2022, then surged by 54.76% to $0.65 in 2023, then surged by 62.87% to $1.06 in 2024, then skyrocketed by 35.08% to $1.43 in 2025.
  • Its last three reported values are $1.43 in Q3 2025, $1.33 for Q2 2025, and $0.93 during Q1 2025.